Once Upon a Farm (OFRM) Q4 2025 earnings review
Stellar Post-IPO Top-Line Growth Masked by Profitability Concerns
Once Upon a Farm delivered an explosive debut quarter as a public company, with Q4 net sales growing 30.1% to $64.0M and FY25 sales surging 53.5% to $240.7M. The top-line momentum is undeniable, fueled by massive gains in the Baby Snacks segment and expanded retail distribution. However, the bottom line tells a more cautionary tale. The reported Q4 net income of $22.5M is an illusion created by a $17.7M non-cash derivative valuation swing; actual operating losses worsened to $4.5M. Furthermore, FY26 guidance projects robust 25-29% revenue growth but essentially flat Adjusted EBITDA of $2-$4M, indicating that the company must continue spending heavily on trade and distribution to buy this growth.
🐂 Bull Case
FY25 saw a 42% volume increase, supported by both existing product velocity and successful new introductions. The brand's household penetration is scaling rapidly.
The February 2026 IPO injected $139.3M in net proceeds, retiring revolving credit debt and providing a massive war chest to fund the working capital needed for 2026 expansion.
🐻 Bear Case
Despite guiding for nearly $70M in incremental revenue for FY26, Adjusted EBITDA is projected to stay essentially flat at $2-$4M, implying massive margin compression on the new revenue.
Gross margin for the full year actually compressed by 125 bps due to the heavy slotting fees and cooler placement costs required to gain retail footprint.
⚖️ Verdict: ⚪
Neutral. The company is a hyper-growth machine on the top line, perfectly positioned in a premium category. However, the lack of operating leverage and stable/flat EBITDA guidance suggest a long, expensive path to true profitability.
Key Themes
Baby Snacks Segment Explosive Growth
The Baby Snacks portfolio is accelerating at an unprecedented rate. Q4 net sales in this category surged 91.2% to $18.7M, and full-year sales skyrocketed 226% to $67.4M. This product line has rapidly transformed from a secondary offering into a primary growth engine, nearly matching the legacy Baby Pouches segment in total scale.
Distribution Expansion & Favorable Pricing
Growth is high-quality, driven by a balanced mix of volume (up 42% in FY25) and price/mix improvements. The introduction of newer products commanding higher average selling prices proved that consumers are willing to absorb a premium for the brand.
Premium Organic Macro Trend
Management noted that parents are increasingly committed to high-quality, organic nutrition. This structural macro shift in consumer preferences is providing strong tailwinds for the company's non-GMO, zero-added-sugar value proposition, insulating it somewhat from broader consumer spending pullbacks.
Underlying Operating Losses Worsening
A clear contradiction to the positive Q4 Net Income narrative ($22.5M) is the actual Q4 Loss from Operations, which worsened to $4.5M from $1.4M a year ago. The net income figure was artificially inflated by a $17.7M non-cash change in fair value of a derivative liability. Operationally, the core business is still burning cash as SG&A scales aggressively.
Trade Spend Eroding Annual Gross Margins
While Q4 saw a localized gross margin bump (47.7%), the full-year narrative is reversing. FY25 gross margin declined 125 basis points to 42.3%. Management cited increased trade spending, specifically slotting fees, cooler placements, and dairy category resets. Gaining shelf space is proving highly expensive.
Zero Operating Leverage in FY26
The most glaring concern is the FY26 guidance. Management expects $302M-$310M in sales, an addition of roughly $65M to the top line. Yet, Adjusted EBITDA is guided at just $2M-$4M, practically stable compared to FY25's $2.1M. This implies zero operating leverage and signals that elevated SG&A and trade spend will eat 100% of the gross profit from new sales.
Other KPIs
Accelerating in absolute terms, though decelerating as a percentage of sales (40.7% vs 43.9% in the prior year). The absolute dollar increase of $4.4M YoY outpaced gross profit gains, dragging the company into a deeper operating loss for the quarter.
Reversing significantly from -$11.0M in FY24. The cash burn intensified due to massive investments in inventory (which consumed $25.8M of cash) and accounts receivable ($10.9M) to support the rapid 53% revenue growth.
Stable and steadily growing (+23.4% YoY). While overshadowed by the hyper-growth in Baby Snacks, Kid Pouches remains the foundational bedrock of the company's revenue, representing roughly 49% of total FY25 sales.
Guidance
Decelerating. The implied 25% to 29% YoY growth rate is a step down from the massive 53.5% growth achieved in FY25, but still represents elite top-tier growth for the CPG food category.
Stable. The midpoint of $3M represents virtually no bottom-line progress compared to the $2.1M delivered in FY25. This confirms that 2026 will be another heavy investment year, prioritizing market share capture over profitability.
Key Questions
Long-Term Margin Target
With FY26 guidance implying an Adjusted EBITDA margin of roughly 1%, what is the timeline and revenue scale required to achieve a mid-to-high single-digit EBITDA margin?
Trade Spend Normalization
How much of the FY25 and planned FY26 trade spend (slotting fees, retail coolers) is a one-time capital/entry cost versus an ongoing requirement to maintain shelf space?
Baby Snacks Cannibalization
Given the explosive 226% growth in the Baby Snacks segment, are you seeing any cannibalization of the traditional Baby Pouches volume, or is this entirely incremental basket size?
Capital Deployment
With nearly $140M in fresh IPO proceeds and debt retired, how aggressively will you pursue inorganic growth (M&A) versus deploying this purely into working capital for the core brand?